Most recently, ATP8B1 was identified as a prognostic biomarker for prostate cancer and lung squamous cell carcinoma, and that a higher ATP8B1 expression was associated with a better patient prognosis [233,234]. The gene discussed is ATP8B1; the disease is prostate carcinoma.